Health System Barriers to Access and Use of Magnesium Sulfate for Women with Severe Pre-Eclampsia and Eclampsia in Pakistan: Evidence for Policy and Practice

PLoS ONE

Volumn 8, Issue 3, 2013, Pages

  Bigdeli, Maryam ^a   Zafar, Shamsa ^b   Assad, Hafeez ^b   Ghaffar, Adbul ^a  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

^b HEALTH SERVICES ACADEMY   (Pakistan)

Author keywords

[No Author keywords available]

Indexed keywords

MAGNESIUM SULFATE;

ARTICLE; DISEASE SEVERITY; DRUG COST; DRUG MANUFACTURE; DRUG MARKETING; DRUG USE; GOVERNMENT REGULATION; HEALTH CARE ACCESS; HEALTH CARE DELIVERY; HEALTH CARE PLANNING; HEALTH CARE POLICY; HEALTH CARE PRACTICE; HEALTH PERSONNEL ATTITUDE; HUMAN; PAKISTAN; PREECLAMPSIA;

ATTITUDE OF HEALTH PERSONNEL; ECLAMPSIA; FEMALE; HEALTH FACILITIES; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MAGNESIUM SULFATE; MATERNAL MORTALITY; PAKISTAN; PRE-ECLAMPSIA; PREGNANCY;

EID: 84875441774     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0059158     Document Type: Article

References (20)

1. Villar J, Say L, Shennan A, Lindheimer M, Duley L, et al. (2004) Methodological and technical issues related to the diagnostic, screening, prevention and treatment of pre-eclampsia and eclampsia. Int J Gynaecol Obstet 85: S28-41.
2. Altman D, Carolli G, Duley L, Farrell B, Moodley J, et al. (2002) Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The magpie trial: a randomised placebo-controlled trial. Lancet 359: 1877-90.
3. The Magpie Trial Follow-up Study Collaborative Group (2007) The Magpie Trial: a randomised trial comparing magnesium sulfate with placebo for pre-eclampsia. Outcome for women at 2 years. BJOG 114: 300-9.
4. Duley L, Gulmezoglu A, Henderson-Smart DJ, Chou D, (2010) Magnesium sulphate and other anticonvulsants for women with pre-eclampsia (Review). Cochrane Database of Syst Rev 11: CD000025.
5. WHO (2011) Priority medicines for mothers and children. World Health Organization, Geneva, Switzerland. WHO/EMP/MAR/2011.1. Available: http://www.who.int/medicines/publications/A4prioritymedicines.pdf.
6. WHO (2010) "Packages of interventions for family planning, safe abortion care, maternal, newborn and child health". World Health Organization, Geneva, Switzerland. WHO/FCH/10.06. Available: http://whqlibdoc.who.int/hq/2010/WHO_FCH_10.06_eng.pdf.
7. Partnership for Maternal, Newborn and Child Health (2010) Knowledge Summary 5: Women's and children's health. Provide Essential Commodities. Available: http://portal.pmnch.org/downloads/low/KS5-low.pdf.
8. Lumbiganon P, Metin Gulmezoglu A, Piaggio G, Langer A, Grimshaw J, (2007) Magnesium suflate is not used for pre-eclampsia and eclampsia in Mexico and Thailand as much as it should be. Bull World Health Organ 85: 763-767.
9. Sevene E, Lewin S, Mariano A, Woelk G, Oxman AD, et al. (2005) System and market failures: the unavailability of magnesium sulphate for the treatment of eclampsia and pre-eclampsia in Mozambique and Zimbabwe. BMJ 331: 765-9.
10. Ridge AL, Bero LA, Hill SR, (2010) Identifying barriers to the availability and use of Magnesium Sulphate Injection in resource poor countries: A case study in Zambia. BMC Health Serv Res 10: 340.
11. National Institute of Population Studies (NIPS), and Macro International Inc. 2008. Pakistan. Demographic and Health Survey 2006-07. National Institute of Population Studies and Macro International Inc., Islamabad, Pakistan.
12. Bigdeli M, Jacobs B, Tomson G, Laing R, Ghaffar A,et al. (2012) Access to medicines from a health system perspective. Health Policy Plan. Nov 2012 [Epub ahead of print]. doi: 10.1093/heapol/czs108.
13. National essential medicines list of Pakistan 2007, 4th revision. Ministry of Health, Labour and Social Welfare, National Government of Pakistan. Islamabad, Pakistan.
14. Curricula for community midwives (2005) Pakistan Nursing Council, Islamabad, Pakistan.
15. Karachi Declaration on scaling up maternal, newborn, child health and family planning best practices (2009) Ministry of Health, Labour and Social Welfare, National Government of Pakistan. Islamabad, Pakistan.
16. Aaserud M, Lewin S, Innvaer S, Paulsen EJ, Dahlgren AT, et al. (2005) Translating research into policy and practice in developing countries: a case study of magnesium sulphate for pre-eclampsia. BMC Health Serv Res 5: 68.
17. Sheikh K, Gilson L, Agyepong IA, Hanson K, Ssengooba F, et al. (2011) Building the field of health policy and systems research: framing the questions. Plos Med 8: e1001073.
18. Gilson L, Hanson K, Sheikh K, Agyepong IA, Ssengooba F, et al. (2011) Building the field of health policy and systems research: social science matters. Plos Med 8: e1991079.
19. Paina L, Peter DH, (2011) Understanding pathways for scaling up health services through the lens of complex adaptive systems. Health Policy Plan 5: 365-73.
20. van Kammen J, de Savigny D, Sewankambo N, (2006) Using knowledge brokering to promote evidence-based policy-making: The need for support structures. Bull World Health Organ 84: 608-12.